New York, NY, May 3, 2022 — HITLAB announced today that Pat Verduin, Chief Technology Officer, Colgate-Palmolive Company has joined the Breakthrough Alliance (BTA) board. Colgate-Palmolive is a leading consumer goods company, guided by its purpose as a caring, innovative growth company reimagining a healthier future for all people, their pets and our planet. 

The BTA is a digital health consortium of executive leaders from across life science, pharmaceutical, academic medical institutions and healthcare providers including New York City Economic Development Corporation, Merck Global Health Innovation, Johnson & Johnson,  Fund LLC, BDO, Atlas Venture, StartUp Health, CATALAIZE, Consummate Capital, EdgeOne Medical, Esplanade Ventures, FFF, and Northwell Health, all committed to improving health outcomes and care delivery through verified emerging technologies. The board is chaired by Bill Taranto, the CEO of the Merck Global Innovation Fund.   


The BTA board meets every quarter. All members have the benefits of:  

  • Setting priorities to guide the development of research studies for selected digital health technologies  
  • Receiving exclusive access to investment and partnership opportunities with the latest digital health tech under development   
  • Gaining insights into the future of digital health by seeing the results of the verified and risk-reduced studies.   

“I am personally delighted to welcome Pat as a new board member,” said Bill Taranto, CEO of Merck Global Health Innovation Fund and Chair of HITLAB BTA. “With her strong technical expertise coupled with her experience working in health and wellness, she is an ideal addition to the board. I look forward to working with her.”   

“The work HITLAB is doing in the healthcare space reflects Colgate-Palmolive’s purpose to reimagine a healthier future for all. I am honored and excited to serve on the BTA board,” said Pat Verduin, Chief Technology Officer, Colgate-Palmolive. “I look forward to working with HITLAB and the board to further their mission and goals.”  


Media Contact: Rachel Fredman  – –  (516) 528-1320 

Explore Recent Posts

HITLAB’s Breakthrough Alliance Challenge opens doors and windows for innovative start-ups

For over twenty years, HITLAB has been a pioneer in the advancement of digital health research, strategy, and education. In 2016, the New York City Economic Development Corporation (NYCEDC) partnered with HITLAB to launch the Digital Health Breakthrough Network (DHBN) as part of its broader efforts to facilitate growth in New York City’s healthcare and life sciences sectors.

Digital Health Leaders Gathered to Share the Latest Evidence During April Symposium

Virtual event brings together health executives from across the industry to share insights on the impact of digital health on human rights. New York, NY, USA. On Thursday, October 27th, HITLAB will host its October Digital Health Symposium focused on digital health and human rights. Moona, MST and Cancer Center.AI are digital health organizations, part of Americas Continental Health Alliance (ACHA), who are currently making a global impact.